Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Developmental Biology / CRISPR/Cas9 Technology in Restoring Dystrophin…
JoVE Journal
Developmental Biology

A subscription to JoVE is required to view this content.

JoVE Journal Developmental Biology
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Journal (Developmental Biology)
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Culture of Embryonic Mouse Cochlear Explants and Gene Transfer by Electroporation
Journal (Developmental Biology)
Culture of Embryonic Mouse Cochlear Explants and Gene Transfer by Electroporation
 

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Article DOI: 10.3791/59432-v • 07:44 min • September 14th, 2019
September 14th, 2019 •
1, 1, 1, 1, 1
1Medical College of Georgia, Augusta University

Chapters

Summary
Automatic Translation

Here, we present a Cas9-based exon23 deletion protocol to restore dystrophin expression in iPSC from Dmdmdx mouse-derived skin fibroblasts and directly differentiate iPSCs into myogenic progenitor cells (MPC) using the Tet-on MyoD activation system.

Tags

CRISPR/Cas9 Technology Restoring Dystrophin Expression IPSC-derived Muscle Progenitors Duchenne Muscular Dystrophy Gene Editing Stem Cells Regeneration Autologous Therapy Genetic Correction Congenital Diseases Cell Reprogramming Gene Editing Technique
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter